Navigation Links
Useful drug for stem cell transplant problem

A new drug rescues patients suffering potentially fatal liver complications from cancer therapy. Generally high doses of chemotherapy are given before a stem cell transplant// such as a bone marrow transplant is used for cancer treatment. But chemotherapy causes five to 50 per cent of such patients to experience a potentially fatal complication called veno-occlusive disease (VOD), which damages circulation in the liver.

In this trial, headed by scientists at Dana-Farber Cancer Institute in the US, a group of 80 patients with severe VOD received a new drug. Defibrotide is extracted from pig intestinal tissue. Around a third of the patients experienced complete reversal of VOD and 35 per cent of them survived for at least 100 days after their transplant.

This is important for only 10 per cent of this desperately ill group would be able to survive this long with usual care. The standard treatment for VOD is clot-busting drugs, which have been linked with severe bleeding and are ineffective once the patient has multiple organ failure.


'"/>




Page: 1

Related medicine news :

1. Useful Cancer drug stops tumour blood supply
2. Useful device makes spinal surgery safer
3. The Drug Tetrathiomolybdate Found To Be Useful For Various Diseases
4. Calcium Supplements May Not Be Useful After A Certain Threshold Is Achieved
5. Viagra May Be Useful For Serious Lung Disease
6. Radiologists Find New CT Scans Useful
7. Antiviral Drugs May Be Useful For Easing Shingles Pain
8. Anti-Parasitic Drugs Useful in Reducing Damages of Congenital Toxoplasmosis
9. Internet Searches Fail To Give Useful Information To Cancer Patients
10. New Research May Be Useful for Developing Drugs for HIV and Cancer
11. Codeine As Useful As A Placebo
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/22/2017)... ... August 22, 2017 , ... ... is the creation of published author, Julianne Hale, a consultant for the Intelligence ... and counter-terrorism expert focusing on the Near East region. Julianne has written ...
(Date:8/22/2017)... North Carolina (PRWEB) , ... August 22, 2017 ... ... strategic advisor. Mr. Stewart is the Founder and Managing Member for t4 Leadership ... that have become critical to his definition of “success”: physician leadership development, servant ...
(Date:8/22/2017)... ... 22, 2017 , ... “Call Of Spiritual Duty”: a revelation in an era ... C.S. Lizarde. Growing up on the streets of North Visalia, California, Carlos Lizarde ... apply the Biblical keys to his life, he noticed immediately that opportunities and blessings ...
(Date:8/21/2017)... (PRWEB) , ... August 22, 2017 , ... PracticeMatch, a ... to help healthcare employers connect with physicians and advanced practitioners like nurse practitioners ... career fairs in August through November of this year. The online career fairs ...
(Date:8/21/2017)... ... August 22, 2017 , ... ... Stevens as a 2017-2018 inductee into its VIP Woman of the Year ... is the nation’s leading networking organization exclusively for professional women, boasting more than ...
Breaking Medicine News(10 mins):
(Date:8/4/2017)... ROCKVILLE, Md. , Aug. 4, 2017 ... during or shortly after a physician/patient consult has long ... industry, and was a notable focus of the largest ...  This is according to healthcare market research firm Kalorama ... of care testing (POCT) offerings or related supplies and ...
(Date:8/2/2017)... 2017   Marshall County Hospital in Benton, Kentucky has ... of hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ... pathogens such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:7/31/2017)...  Diplomat Pharmacy, Inc. (NYSE: DPLO), has been named one ... by Crain,s Detroit Business . The annual ... three-year revenue growth. This year,s edition measures growth from 2013 ... the complete list, visit crainsdetroit.com/awards/fast_50/2017 .  ... said Phil Hagerman , CEO and chairman of Diplomat. ...
Breaking Medicine Technology: